464 results found

Secondary migration occurs on trans-anatomical planes as the result of mesh erosion caused by foreign body reaction.

In Valeant Canada LP/Valeant Canada S.E.C. v. British Columbia, 2022 BCCA 366, the BC Court of Appeal struck a public nuisance claim against manufacturers and distributors of prescription...

Bill C-17, "An Act to amend the Food and Drugs Act" was introduced to Parliament by the Minister of Health on December 6, 2013.

In aquaculture, it took over two decades and $80 million in capital for the genetically modified salmon made by AquaBounty to be developed and approved by regulators for sale in Canada and the US.

The federal government has passed the Canada Consumer Product Safety Act (CCPSA), which will come into force on June 20, 2011.

Certification was denied in a recent proposed multiple-model product liability class action before the Ontario Superior Court of Justice in O’Brien v Bard Canada Inc. We acted for the defendants.

When you purchase a product in British Columbia, you have the right to expect it will be safe for its intended use. Unfortunately, defective products sometimes enter the marketplace, causing serious injuries and financial losses to consumers.

A recent decision of the Ontario Superior Court of Justice summarized the law in Canada concerning a medical device manufacturer's duty to warn in the context of class action litigation.

Are you among the millions of Canadians who buy and use the popular blue product Lysol Advanced? Not only does it kill 99.9% of bacteria, it can also corrode metal. It is a safe bet (or at least it is hoped)...

The new "Product of Canada" guidelines came into effect on December 31, 2008, and were published as the new paragraph 4.19 in the Guide to Food Labelling: "a food product may claim ‘Product of Canada’ when all or virtually all major ingredients, processing and labour used to make the food product are Canadian."

The Supreme Court of Canada declined to hear an appeal of a decision of the Court of Appeal for Ontario that limits claims in class actions against manufacturers.

Described as the future of the internet, the metaverse is at an early stage but is gaining momentum. While a virtual-reality parallel universe is likely several years away, entirely new areas of law...

At a time of year when the days are shortest, is it any wonder that we take such delight in seeing so many twinkling little lights, both inside and outside our homes?

Class Action Case Update: Justice Perell's recent decision in Wise v Abbott Laboratories, Limited, 2016 ONSC 7275 addressed a number of key areas of interest for the class action bar.

The Ontario Court of Appeal decision in 1688782 Ontario Inc. v. Maple Leaf Foods Inc. is among the first rulings to apply the duty of care analysis from the Supreme Court of Canada's 2017 Livent ruling.

Could gun manufacturers and distributors be held liable in Ontario for firearms trafficked from the U.S. and used in Canadian crimes? This analysis examines how product liability law, successfully applied to opioids and tobacco, might offer a new approach to gun violence beyond traditional criminal enforcement strategies.

A recent Ontario Superior Court decision denying certification of a pharmaceutical class action could have a significant impact on the conduct of product liability class actions in the province. In rejecting certification, the court closely analyzed the claim being advanced and the common issues proposed and concluded the action was not suitable for certification.